Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related ADTN
A&T To Cut 2015 Cap Ex 14%; Shares Of Suppliers Sink
UPDATE: ADTRAN Q3 Profit Tops Street View
Related MDT
UPDATE: Medtronic plc: FDA Approves the VenaSeal Closure System for Treatment of Clinically Symptomatic Venous Reflux
3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis
Seeking Alpha's Biotech Weekly: AbbVie - Pharmacyclitics, Orexigen Confusion, And More (Seeking Alpha)

Analysts at Citigroup upgraded ADTRAN (NASDAQ: ADTN) from “sell” to “neutral.” ADTRAN's stock closed at $21.96 yesterday. ADTRAN had $228.94 million in total cash for the latest quarter.

Credit Suisse upgraded Medtronic (NYSE: MDT) from “neutral” to “outperform.” Medtronic's shares closed at $43.94 yesterday. Medtronic's PEG ratio is 2.23.

Analysts at JP Morgan upgraded Juniper Networks (NYSE: JNPR) from “neutral” to “overweight.” Juniper's shares closed at $20.98 yesterday. Juniper's trailing-twelve-month revenue is $4.35 billion.

Macquarie upgraded Mercury General (NYSE: MCY) from “neutral” to “outperform.” Mercury General's shares closed at $39.17 yesterday. Mercury General's trailing-twelve-month operating margin is 10.10%.

Latest Ratings for ADTN

DateFirmActionFromTo
Oct 2014Goldman SachsAssumesBuy
Oct 2014JP MorganMaintainsNeutral
Jul 2014MKM PartnersMaintainsNeutral

View More Analyst Ratings for ADTN
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ADTN + JNPR)

Around the Web, We're Loving...